Faster-acting insulins are especially beneficial for patients on continuous glucose monitors who are keeping track of glucose peaks and valleys.

Research presented at EASD 2017 shows that dapagliflozin may reduce insulin requirements with a low risk of adverse effects in patients with type 1 diabetes.

Dr Paul Grewal shares his story of his battle against obesity and how he uses his personal struggle to support his patients with obesity and diabetes.

Managing blood sugar during and after exercise can be challenging, but clinicians can help patients avoid highs and lows.

Not only is kidney disease common in diabetes, it's also inextricably linked to CVD.

CDC reviews the latest vaccine recommendations for adults, including patients with chronic medical conditions.

In our next wave of study designs, we must be more creative and come up with more innovative trials of antihyperglycemic drugs, says Dr Lawrence Leiter.

Reported increases in minority children diagnosed with type 2 diabetes has researchers wondering whether environmental causes and gestational diabetes are to blame.

New REMOVAL data presented at EASD 2017 reveal effects of metformin on renal function, biomarkers, and more in patients with type 1 diabetes.

Changes in the DSM-5 and ICD-11 are meant to improve accuracy and reduce stigma but retain access to care, says Dr Jack Drescher.